Vnitr Lek 2006, 52(10):957-962

Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency

M. Marunová
Endokrinologický ústav, Praha, ředitel doc. MUDr. Vojtěch Hainer, CSc.

Deficiency of 3β-hydroxysteroid dehydrogenase belongs to less frequent types of congenital adrenal hyperplasia. It is a deficiency of the enzyme converting pregnenolon to progesteron, 17-OH-pregnenolon to 17-OH-progesteron and dehydroepiandrosteron to androstendion in the adrenal glands and gonads. Exact prevalence of forms with clinical symptoms is known; however, it is less frequent compared to deficiency of 21-hydroxylase. Clinical manifestation is very variable, from serious salt disorder, ambiguous genitalia and precocious puberty to oligosymptomatic forms with late effects or asymptomatic forms. No routine genetic analysis in Czech republic is available. Diagnosis can be suspected through increased levels of some steroid hormones in basal condition; the final determinent indicator is the concentration of steroid hormones after stimulation by adrenocorticotropic hormone.

Keywords: 3β-hydroxysteroid dehydrogenase; hypogonadism; congenital adrenal hyperplasia; cortisol

Received: June 26, 2006; Published: October 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marunová M. Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency. Vnitr Lek. 2006;52(10):957-962.
Download citation

References

  1. Alos N, Moisan AM, Ward L et al. A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3β-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty. J Clin Endocrinol Metab 2000; 85: 1968-1974. Go to original source...
  2. Cavanah SF, Dons RF. Partial 3-β-hydroxysteroid dehydrogenase deficiency presenting as new-onset gynecomastia in a eugonadal adult male. Metabolism 1993; 42: 65-68. Go to original source... Go to PubMed...
  3. Gingras S, Simard J. Induction of 3β-hydroxysteroid dehydrogenase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon and cervix cancer cell lines. Endocrinology 1999; 140: 4573-4584. Go to original source... Go to PubMed...
  4. Chang BL, Zheng SL, Hawkins GA et al. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. Cancer Res 2002; 62: 1784-1789.
  5. Chang YT, Kappy MS, Iwamoto K et al. Mutations in the type II 3β-hydroxysteroid dehydrogenase gene in a patient with classic salt wasting 3β-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia. Pediatr Res 1993; 34: 698-700. Go to original source... Go to PubMed...
  6. Johannsen TH, Mallet D, Dige-Petersen H et al. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3 β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 2005; 90: 2076-2080. Go to original source... Go to PubMed...
  7. Kotaška K, Lisá L, Průša R. Common CYP21 gene mutations in Czech patients and statistical analysis of worldwide mutation distribution. Centr Eur J Public Health 2003; 11: 124-128.
  8. Labrie F, Simard J, Luu-The V et al. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol 1992; 43: 805-826. Go to original source... Go to PubMed...
  9. Lisá L. Vrozená adrenální hyperplazie. Praha, Triton 2004.
  10. Lutfallah C, Wang W, Mason JI et al. Newly proposed hormonal criteria via genotypic proof for type II 3β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 2002; 87: 2611-2622. Go to original source...
  11. Marunová M. Kongenitální adrenální hyperplazie s neúplným deficitem 3-β hydroxysteroidní dehydrogenázy u dospělého muže. Kazuistiky v diabetologii 2006; 4: 34-40.
  12. Mason JI. The 3β-hydroxysteroid dehydrogenase gene family of enzymes. Trends Endocrinol Metab 1993; 4: 199-202. Go to original source... Go to PubMed...
  13. Mauri M, Castro A, Latronico C et al. Mutations in the type II 3β-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls. Clin Endocrinol 2000; 52: 67-75. Go to original source... Go to PubMed...
  14. McBride MW, McVie AJ, Burridge SM et al. Cloning, expression, and physical mapping of the 3β-hydroxysteroid dehydrogenase gene cluster (HSD3BP1-HSD3BP5) in human. Genomics 1999; 61: 277-284. Go to original source... Go to PubMed...
  15. Mermejo LM, Elias LL, Marui S et al. Refining hormonal diagnosis of type II 3β-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping. J Clin Endocrinol Metab 2005; 90: 1287-1293. Go to original source... Go to PubMed...
  16. Moisan AM, Ricketts ML, Tardy V et al. New insight in mutations in the HSD3B2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes. J Clin Endocrinol Metab 1999; 84: 4410-4425. Go to original source...
  17. New MI. Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol 2003; 211: 75-83. Go to original source... Go to PubMed...
  18. Pang S, Carbunaru G, Haider A et al. Carriers for type II 3β-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test. Clin Endocrinol (Oxf) 2003; 58: 323-331. Go to original source... Go to PubMed...
  19. Roberts RO, Bergstralh EJ, Farmer SA et al. Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia. Prostate 2006; 66: 392-404. Go to original source... Go to PubMed...
  20. Rosmond R, Chagnon M, Bouchard C et al. Polymorphism in exon 4 of the human 3β-hydroxysteroid dehydrogenase type I gene (HSD3B1) and blood pressure. Biochem Biophys Res Commun 2002; 293: 629-632. Go to original source... Go to PubMed...
  21. Simard J, Rheaume E, Sanchez R et al. Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol 1993; 7: 716-728. Go to original source...
  22. Simard J, Moisan AM, Morel Y. Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase/delta5-delta4 isomerase deficiency. Semin Reprod Med 2002; 20: 255-276. Go to original source... Go to PubMed...
  23. Zhang L, Mason I, Naiki Y et al. Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene causing respectively, nonsalt wasting and salt-wasting 3βHSD deficiency disorder. J Clin Endocrinol Metab 2000; 85: 1678-1685. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.